Suraksha Diagnostic IPO: Stock to debut on Friday. Here's what GMP indicates about listing
Suraksha Diagnostic is set to list on Friday. The stock is trading with a GMP of Rs 15 in the grey market. The IPO was subscribed 1.27 times. The company is the largest full-service diagnostic chain in East India.

Considering the upper price band of Rs 441, the stock is expected to see a marginal premium of 3% over the issue price.
However, it is important to note that grey market premiums are just an indicator as to how the company's shares are stacked up in the unlisted market and are subject to change rapidly.
The IPO of Suraksha Diagnostic just managed to sail through on the last day of the bidding process after getting muted response on the first two days. The overall subscription stood at 1.27 times the shares on offer at close.
Also Read: Will Pushpa 2 excitement make loss-making PVR Inox a screaming buy for investors?
Since the IPO is completely an OFS, the company will not receive any proceeds from the issue.
Its operational network consists of a flagship central reference laboratory, 8 satellite laboratories and 194 customer touchpoints which include 48 diagnostic centres, and 146 sample collection centres (primarily franchised), across the states of West Bengal, Bihar, Assam, and Meghalaya, as of March 31, 2024.
During fiscal 2024, it conducted nearly 5.98 million tests serving approximately 1.14 million patients.
According to a Crisil report, the diagnostics services market in India is estimated to be around Rs 86,000-87,000 crore in fiscal 2024 and is projected to grow at a CAGR of around 10% to 12% to reach approximately Rs 1,27,500 - Rs 1,37,500 crore by fiscal 2028.
Download ET Markets APP